Somerset Indus Capital Partners has successfully closed its third fund (Fund III) at $288 million, surpassing its initial target of $250 million, reflecting strong investor confidence in its healthcare-focused investment strategy.

Key Highlights

• Somerset Indus closes $288 million Fund III to invest in scalable healthcare businesses across India.
• Fund targets underserved markets focusing on hospitals diagnostics and affordable healthcare solutions in Tier II cities.

The fund attracted a diverse pool of global institutional investors, including development finance institutions, investment firms, domestic financial institutions, insurance companies, family offices, and impact investors from regions such as Europe, the United States, and Southeast Asia.

Fund III will primarily focus on addressing healthcare access gaps across India’s “missing middle,” especially in Tier II and Tier III cities. The firm plans to invest in scalable healthcare businesses spanning hospitals, pharmaceuticals, medical devices, diagnostics, and allied sectors, with a strong emphasis on affordability and accessibility.

Also Read: PE-VC Investments Hit $2.6 Billion in February 2026

Typically, the firm invests between $15 million and $40 million per company, but it retains the flexibility to participate in larger deals of up to $60–80 million through co-investments alongside its limited partner network.

The new fund has already deployed capital into companies such as Cyrix Healthcare, Printmann Offset, and NU Hospitals, indicating active deal-making momentum.

Somerset’s earlier funds have demonstrated strong performance, with Fund I delivering around 4x DPI and Fund II progressing toward exits, reinforcing its track record in the healthcare investment space.